Close Menu

NEW YORK (GenomeWeb) — The Addario Lung Cancer Medical Institute (ALCMI) announced this week that it has partnered with the Dana-Farber Cancer Institute on a nationwide study investigating the causes of treatment resistance in a subset of non-small cell lung cancer (NSCLC) patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.